L-Polamidon (Levomethadone Hydrochloride)

• Levomethadone Hydrochloride is indicated for conditions involving opioid pathways, primarily pain and dependence.
• Chronic pain: provides potent analgesia for patients requiring long‑term opioid therapy.
• Opioid dependence: used in maintenance programs to reduce withdrawal symptoms and cravings.
• Severe cancer pain: offers strong pain relief when other opioids are insufficient.

• Levomethadone Hydrochloride acts as a full agonist at the mu‑opioid receptor in the central nervous system. By binding to these receptors, it inhibits the transmission of nociceptive signals and produces analgesia. The same receptor activation also modulates reward pathways, which underlies its utility in opioid dependence maintenance therapy. Its high affinity and intrinsic activity result in prolonged receptor activation compared with racemic methadone.

Levomethadone Hydrochloride may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Constipation: reduced bowel motility.
• Dizziness: sensation of light‑headedness.
• Drowsiness: increased sleepiness.
• Dry mouth: reduced salivation.
• Sweating: excessive perspiration.

Serious or Rare Side Effects

• Respiratory depression: reduced breathing effort, potentially life‑threatening.
• QT interval prolongation: risk of cardiac arrhythmias.
• Severe hypotension: marked drop in blood pressure.
• Allergic reactions: rash, itching, or anaphylaxis.
• Seizures: rare neurologic events.
• Adrenal insufficiency: impaired stress response.

• When prescribing Levomethadone Hydrochloride, clinicians should observe several safety considerations.
• Assess respiratory function: monitor for depression, especially during dose initiation or escalation.
• Evaluate cardiac status: consider risk of QT interval prolongation and arrange ECG monitoring as needed.
• Avoid use in severe hepatic impairment: dose adjustment may be required.
• Use cautiously in renal impairment: monitor for accumulation.
• Monitor for signs of dependence or abuse: implement appropriate risk‑mitigation strategies.
• Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levomethadone Hydrochloride can interact with other medicines, affecting its safety and efficacy.

Major Interactions (Avoid)

• Concomitant CNS depressants (e.g., benzodiazepines, alcohol): risk of profound respiratory depression.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase plasma concentrations.
• Other opioids: additive opioid effect leading to overdose.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce effectiveness.
• Serotonergic agents (e.g., SSRIs, tramadol): potential for serotonin syndrome.
• Antihistamines or anticholinergics: may enhance anticholinergic side effects.